Korea Investment Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$276M Sell
1,267,180
-249,071
-16% -$55.2M 0.57% 23
2025
Q4
$346M Sell
1,516,251
-33,899
-2% -$7.72M 0.68% 19
2025
Q3
$359M Buy
1,550,150
+188,587
+14% +$38.4M 0.74% 19
2025
Q2
$253M Buy
1,361,563
+20,223
+2% +$3.76M 0.56% 26
2025
Q1
$281M Buy
1,341,340
+16,502
+1% +$3.21M 0.68% 23
2024
Q4
$235M Sell
1,324,838
-34,505
-3% -$6.34M 0.56% 25
2024
Q3
$268M Buy
1,359,343
+117,288
+9% +$21.9M 0.64% 24
2024
Q2
$213M Sell
1,242,055
-185,721
-13% -$30.8M 0.54% 29
2024
Q1
$260M Sell
1,427,776
-97,416
-6% -$16.8M 0.66% 24
2023
Q4
$236M Buy
1,525,192
+74,883
+5% +$10.9M 0.62% 25
2023
Q3
$216M Buy
1,450,309
+101,085
+7% +$14.8M 0.64% 25
2023
Q2
$182M Sell
1,349,224
-102,013
-7% -$15M 0.51% 36
2023
Q1
$231M Sell
1,451,237
-38,165
-3% -$5.83M 0.67% 26
2022
Q4
$241M Sell
1,489,402
-58,298
-4% -$8.94M 0.76% 25
2022
Q3
$208M Buy
1,547,700
+11,236
+0.7% +$1.61M 0.64% 26
2022
Q2
$235M Buy
1,536,464
+136,988
+10% +$20.9M 0.72% 27
2022
Q1
$227M Buy
1,399,476
+249,807
+22% +$36.3M 0.56% 28
2021
Q4
$156M Buy
1,149,669
+76,823
+7% +$9.07M 0.4% 56
2021
Q3
$116M Buy
1,072,846
+57,560
+6% +$6.58M 0.35% 67
2021
Q2
$114M Buy
1,015,286
+24,380
+2% +$2.75M 0.33% 77
2021
Q1
$107M Sell
990,906
-112,204
-10% -$12M 0.34% 72
2020
Q4
$118M Sell
1,103,110
-151,608
-12% -$14.6M 0.36% 67
2020
Q3
$110M Sell
1,254,718
-54,900
-4% -$5.17M 0.39% 61
2020
Q2
$129M Buy
1,309,618
+393,338
+43% +$34.6M 0.47% 47
2020
Q1
$69.8M Sell
916,280
-165,000
-15% -$14.1M 0.31% 83
2019
Q4
$95.7M Buy
1,081,280
+42,900
+4% +$3.56M 0.35% 62
2019
Q3
$78.6M Buy
1,038,380
+50,800
+5% +$3.48M 0.33% 69
2019
Q2
$71.8M Sell
987,580
-51,000
-5% -$4.01M 0.31% 78
2019
Q1
$83.7M Buy
1,038,580
+25,480
+3% +$2.08M 0.38% 58
2018
Q4
$93.4M Sell
1,013,100
-50,100
-5% -$4.41M 0.51% 42
2018
Q3
$101M Sell
1,063,200
-151,867
-12% -$14.4M 0.46% 46
2018
Q2
$113M Sell
1,215,067
-10,500
-0.9% -$1.03M 0.51% 40
2018
Q1
$116M Buy
1,225,567
+22,102
+2% +$2.43M 0.54% 38
2017
Q4
$116M Buy
1,203,465
+127,300
+12% +$12M 0.53% 36
2017
Q3
$95.6M Buy
1,076,165
+46,340
+4% +$3.53M 0.44% 43
2017
Q2
$74.7M Buy
1,029,825
+22,699
+2% +$1.53M 0.35% 61
2017
Q1
$65.6M Buy
1,007,126
+165,064
+20% +$10.4M 0.33% 64
2016
Q4
$52.7M Sell
842,062
-747,778
-47% -$45.6M 0.25% 107
2016
Q3
$100M Buy
1,589,840
+160,362
+11% +$10.4M 0.53% 38
2016
Q2
$88.5M Buy
1,429,478
+240,000
+20% +$14.6M 0.53% 41
2016
Q1
$67.9M Sell
1,189,478
-73,400
-6% -$4.09M 0.5% 41
2015
Q4
$74.8M Buy
1,262,878
+73,300
+6% +$4.22M 0.52% 38
2015
Q3
$64.7M Buy
1,189,578
+212,278
+22% +$13.8M 0.52% 35
2015
Q2
$65.7M Sell
977,300
-121,000
-11% -$7.9M 0.56% 32
2015
Q1
$64.3M Buy
1,098,300
+276,000
+34% +$16.7M 0.5% 39
2014
Q4
$53.8M Sell
822,300
-31,100
-4% -$1.96M 0.44% 45
2014
Q3
$49.3M Sell
853,400
-52,600
-6% -$2.92M 0.4% 47
2014
Q2
$51.1M Sell
906,000
-12,800
-1% -$672K 0.43% 46
2014
Q1
$47.2M Sell
918,800
-272,200
-23% -$13.8M 0.42% 47
2013
Q4
$62.9M Buy
1,191,000
+692,800
+139% +$34.1M 0.59% 33
2013
Q3
$22.3M Sell
498,200
-30,600
-6% -$1.36M 0.24% 105
2013
Q2
$21.9M Buy
+528,800
New +$23.1M 0.26% 83

Other funds holding ABBV

Korea Investment Corp's ABBV Position: Q1 2026 in Review

Korea Investment Corp reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $55.2M and leaving 1,267,180 shares worth $276M. The position accounts for 0.57% of the portfolio, ranked #23.

Korea Investment Corp first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $359M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Korea Investment Corp held 1,267,180 shares of AbbVie worth $276M as of Q1 2026.
  • Korea Investment Corp sold 249,071 AbbVie shares in Q1 2026, an estimated $55.2M.
  • AbbVie made up 0.57% of Korea Investment Corp's portfolio in Q1 2026, its #23 holding.
  • Korea Investment Corp first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Korea Investment Corp's AbbVie position peaked at $359M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Korea Investment Corp's 13F filing for Q1 2026, filed 13 May 2026.